A peptide approach to regenerative medicine
Are regenerative peptides the answer to current challenges in the development of treatments for unmet needs?
Read More
Search Results for: Frank Lee, PhD, is CSO, and Yi-Chun Maria Chen, PhD, is VP of Business Development, both at BRIM Biotechnology
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
